Plaintiffs Respond to Drug Makers’ Motion to Dismiss Valsartan Recall Lawsuits
Parties in valsartan litigation have dueling arguments over the validity of the litigation as defendants seek to have the Master Complaint dismissed.…
«
»
Parties in valsartan litigation have dueling arguments over the validity of the litigation as defendants seek to have the Master Complaint dismissed.…
The FDA has issued new guidance on how industry should work to avoid further contamination by NDMA and similar carcinogens.…
The FDA warns that two crucial tuberculosis antibiotic drugs may contain high levels of nitrosamine impurities which may increase cancer risks, but will not recall the drugs due to the risk of a shortage.…
A new study finds that valsartan and similar drugs do not increase the risk of poor outcomes from COVID-19.…
New study questions whether hypertension drugs increase severity of COVID-19.…
The son of a Kansas woman who died of liver cancer says her death was caused by cancer-causing contaminants in recalled generic losartan.…
Industry experts are becoming concerned about the potential amount of drugs which may be contaminated by NDMA, which many never checked their drugs for until now.…
A Delaware health insurance company has filed a class action lawsuit against a number of generic metformin manufacturers due to the presence of NDMA; a known cancer-causing agent.…
Some researcher warn that blood pressure medications like valsartan and Benicar could increase the severity and lethality of the coronavirus.…
A class action lawsuit claims generic brand of metformin contaminated by NDMA are illegal and seeks reimbursement for all those who purchased the tainted diabetes drug.…